Chapel Hill, NC, United States of America

Rickey Roy Rhinebarger

This inventor holds 2 USPTO granted patents. Top assignee: Altum Pharmaceuticals Inc.. Active years: 2020-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rickey Roy Rhinebarger. Retrieved from https://idiyas.com/inventor/rickey-roy-rhinebarger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Rickey Roy Rhinebarger

Introduction

Rickey Roy Rhinebarger is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms for medical treatments. With a total of 2 patents, his work focuses on improving the delivery of essential compounds for therapeutic use.

Latest Patents

Rickey's latest patents include compositions of gallium (III) complexes for oral administration. These inventions relate to dosage forms of gallium complexes that are suitable for oral delivery. The methods of preparation outlined in these patents are designed to enhance the treatment of various diseases, including cancer. His work in this area demonstrates a commitment to advancing medical science and improving patient outcomes.

Career Highlights

Rickey Roy Rhinebarger is currently associated with Altum Pharmaceuticals Inc., where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company and the broader medical community.

Collaborations

Rickey collaborates with talented professionals, including his coworker Gina G Stetsko. Together, they work on projects that aim to push the boundaries of pharmaceutical research and development.

Conclusion

Rickey Roy Rhinebarger is a notable inventor whose work in gallium (III) complexes has the potential to transform treatment options for patients. His dedication to innovation in pharmaceuticals is evident through his patents and ongoing contributions to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…